The HRA are pleased to inform you about updates being made to the combined review system for Clinical Trials of Investigational Medicinal Products (CTIMPs) in the next few days.
Patients across the UK will benefit from a super-charged clinical research system, backed by over £64 million of dedicated investment, which will save lives across the country.
